Conquering Diseases

Study Matching Myeloid Cancer Clinical Trial Opportunities To Individual Blood Or Bone Marrow Biomarkers

Description

Seeking people with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) for a study collecting blood or bone marrow to test for biomarkers to use to match them to a myeloid cancer treatment clinical trial opportunity.

Overview

All participants in this study will have their blood and bone marrow tested for biomarkers. Based on their biomarkers, participants may be approached about myeloid cancer treatment clinical trial opportunities. If you don't match to a trial or decide against clinical trial participation you will receive the standard treatment from your doctor.

What we're hoping for

We are studying if using blood or bone marrow biomarkers to match adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) to study opportunities improves outcomes.

Additional Information

ClinicalTrials.gov Identifier: NCT05564390

 Principal Investigator

Jan  Cerny, MD, PhD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989